Q8: What is the effectiveness, safety and role of pharmacological interventions, by non-specialized health care providers, for the broad category of Disruptive Behaviour Disorders (DBDs), Conduct Disorder (CD), Oppositional Defiant Disorder (ODD) and comorbid (but not exclusively) Attention-Deficit ...Hyperactivity Disorder (ADHD)?
more
Infant Psychiatry
Chapter B.1
Early Maltreatment and exposure to violence
Mood disorders
Chapter E.2
Q10: Are antidepressants (Tricyclic antidepressants (TCA), Selective serotonin reuptake inhibitors (SSRIs)) effective and safe in children 6-12 years of age with depressive episode/disorder?
Anxiety disorders
Chapter F.3
Substance use disorders
Chapter G.3
Other disorders
Chapter H.5
Psychiatrie de l'enfant
Chapitre B.1
Edition en français
Traduction : Apolline Morville
Sous la direction de : Priscille Gérardin
Avec le soutien de la SFPEADA
www.jogh.org • doi: 10.7189/jogh.02.020405 ~ December 2012 • Vol. 2 No. 2 • 020405
WHO's Health in the Green Economy sector briefings examine the health impacts of climate change mitigation strategies considered by the Intergovernmental Panel on Climate Change in their Fourth Assessment Report (Climate Change, 2007). Large, immediate health benefits from some climate change strate...gies are to be expected.
more
Q1: What are the effective maternal mental health interventions to prevent developmental problems in early infancy?
Prevention, early identification, assessment and intervention in low- and middle-income countries | A Review | CHILD AND ADOLESCENT HEALTH AND DEVELOPMENT
Q2: For people with dementia, does memantine, when compared to placebo/comparator, produce benefits/harm in the specified outcomes in non-specialist health settings?
Strengthening health-system emergency preparedness.
Journal of the ASEAN Federation of Endocrine Societies ; Vol.27 No.1 May 2012 ; Page 34-39